SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

The Food and Drug Administration says Abbott's BinaxNOW test and Quidel's QuickVue can be sold without a prescription. FDA Authorizes 2 Rapid, At-Home Coronavirus Tests Imagine waking up, brushing ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rapid tests for the H1N1 pandemic flu are at least 89% accurate ...

Says can add 2009 H1N1 influenza A virus reactivity info Shares rise 6 percent in pre-market trade Sept 17 (Reuters) - Quidel Corp , a provider of rapid diagnostic tests, said it received special ...

Quidel Corporation QDEL has been gaining on the back of its strong diagnostics portfolio. A solid third-quarter 2021 performance, along with solid potential in In-Vitro Diagnostics (“IVD”) products, ...

Rapid tests for the H1N1 pandemic flu are at least 89% accurate -- but only if a tested specimen has a high level of the virus, the CDC said. Overall, the agency said, three major test kits accurately ...